Skip to main content

Table 2 Medical therapy and procedures used in the two periods

From: In-hospital prognosis and long-term mortality of STEMI in a reperfusion network. “Head to head” analisys: invasive reperfusion vs optimal medical therapy

Drugs Pre-network
N = 670
Post-network
N = 598
P value
Aspirin 96.6% 99.3% 0.001
Clopidogrel 54.3% 79.9% <0.001
Ticagrelor ---- 27.9% ----
Prasugrel ---- 3.3% ----
GP IIb/IIIa Inhibitors 16.1% 13.1% 0.252
Heparin 82.1% 93.9% <0.001
Betablockers 69.3% 81.2% <0.001
Statins 89.7% 98.0% <0.001
ACE inhibitors 70.1% 77.8% 0.003
Nitroglicerin 40.6% 37.2% 0.241
Eplerenone ----- 17.9% -----
Mecanichal ventilation 8.5% 8.0% 0.870
Echocardiogram 40.3% 56.0% <0.001
Coronary angiography 55.2% 99.5% <0.001
IABP 4.8% 4.1% 0.680
Swan-Ganz cathether 7.8% 5.1% 0.080
Reperfusion 64.4% 89.2% <0.001
 PPCI 43.9% 99.0% <0.001
 Thrombolysis 56.1% 1.0% <0.001
  1. ACE angiotensin converting enzyme, IABP intra-aortic balloon pump, PPCI primary percutaneous coronary intervention